Respiratory Pharm PDF
Document Details
Uploaded by DeadOnDubnium2576
Auburn University
Tags
Summary
This document discusses respiratory pharmacology, covering Chronic Obstructive Pulmonary Disease (COPD), Asthma, and Pneumonia. It details the pathophysiology and drugs used for each condition.
Full Transcript
1. Chronic Obstructive Pulmonary Disease (COPD) Pathophysiology: COPD is primarily caused by chronic exposure to irritants like smoking, leading to inflammation in the airways and destruction of lung tissue. It involves two main components: ○ Chronic Bronchitis: Chronic inflam...
1. Chronic Obstructive Pulmonary Disease (COPD) Pathophysiology: COPD is primarily caused by chronic exposure to irritants like smoking, leading to inflammation in the airways and destruction of lung tissue. It involves two main components: ○ Chronic Bronchitis: Chronic inflammation and mucus hypersecretion lead to narrowing of the bronchi. ○ Emphysema: Damage to alveolar walls, causing a loss of surface area for gas exchange. This results in airflow limitation that is progressive and not fully reversible. Drugs Used: 1. Bronchodilators (e.g., Beta-2 Agonists, Anticholinergics) ○ MOA: Relaxation of bronchial smooth muscle by beta-2 receptor stimulation or acetylcholine blockade. ○ Therapeutic Use: Relief of bronchospasm in COPD. ○ Side Effects: Tachycardia, tremor, dry mouth, blurred vision. ○ Contraindications/Interactions: Caution in patients with glaucoma, urinary retention, and heart disease. 2. Corticosteroids (e.g., Fluticasone, Budesonide) ○ MOA: Anti-inflammatory action by reducing airway inflammation. ○ Therapeutic Use: Chronic management of COPD, especially in patients with frequent exacerbations. ○ Side Effects: Oral thrush, hoarseness, osteoporosis, weight gain. ○ Contraindications/Interactions: Caution with systemic infections, diabetes, or fungal infections. 3. Phosphodiesterase-4 Inhibitors (e.g., Roflumilast) ○ MOA: Reduces inflammation by inhibiting phosphodiesterase-4, leading to increased cAMP. ○ Therapeutic Use: Used for severe COPD to reduce exacerbations. ○ Side Effects: Diarrhea, weight loss, nausea. ○ Contraindications/Interactions: Liver disease, caution with theophylline. 2. Asthma Pathophysiology: Asthma is a reversible airway obstruction that results from inflammation in the small airways. ○ Key processes: Edema, excess mucus production, and bronchoconstriction. Asthma can be triggered by allergens, respiratory infections, exercise, or irritants. Drugs Used: 1. Short-Acting Beta Agonists (SABA) (e.g., Albuterol) ○ MOA: Beta-2 receptor stimulation, leading to bronchodilation. ○ Therapeutic Use: Fast relief during acute asthma attacks. ○ Side Effects: Tachycardia, palpitations, nervousness. ○ Contraindications/Interactions: Caution in patients with heart disease or hyperthyroidism. 2. Inhaled Corticosteroids (ICS) (e.g., Fluticasone, Budesonide) ○ MOA: Anti-inflammatory, reduce airway inflammation by suppressing immune responses. ○ Therapeutic Use: Long-term control and prevention of asthma symptoms. ○ Side Effects: Oral thrush, hoarseness, systemic side effects (if high doses). ○ Contraindications/Interactions: Avoid in active infections, caution in children (risk of growth retardation). 3. Leukotriene Receptor Antagonists (LTRA) (e.g., Montelukast) ○ MOA: Block leukotriene receptors, preventing bronchoconstriction and inflammation. ○ Therapeutic Use: Asthma maintenance therapy, especially for allergic asthma. ○ Side Effects: Headache, gastrointestinal disturbances. ○ Contraindications/Interactions: Avoid in patients with a history of neuropsychiatric events. 4. Long-Acting Beta Agonists (LABA) (e.g., Salmeterol) ○ MOA: Beta-2 receptor stimulation for sustained bronchodilation. ○ Therapeutic Use: Long-term asthma control in combination with ICS. ○ Side Effects: Tachycardia, tremors, paradoxical bronchospasm. ○ Contraindications/Interactions: Should not be used alone in asthma due to increased risk of exacerbations. 3. Pneumonia Pathophysiology: Pneumonia is an infection of the lungs that leads to inflammation in the alveoli, causing fluid accumulation and impaired gas exchange. ○ It can be caused by bacteria (e.g., Streptococcus pneumoniae), viruses (e.g., Influenza), or fungi. ○ Common symptoms: cough, fever, chills, difficulty breathing, and chest pain. Drugs Used: 1. Antibiotics (e.g., Penicillin, Macrolides) ○ MOA: Penicillin inhibits bacterial cell wall synthesis; Macrolides inhibit bacterial protein synthesis. ○ Therapeutic Use: Treatment of bacterial pneumonia. ○ Side Effects: Diarrhea, allergic reactions, liver toxicity. ○ Contraindications/Interactions: Penicillin contraindicated in patients with penicillin allergies. 2. Antivirals (e.g., Oseltamivir) ○ MOA: Inhibits neuraminidase, preventing viral replication in the host. ○ Therapeutic Use: Treatment of viral pneumonia, particularly influenza. ○ Side Effects: Nausea, headache, fatigue. ○ Contraindications/Interactions: Caution in renal impairment. 3. Oxygen Therapy ○ MOA: Provides supplemental oxygen to maintain adequate blood oxygen levels. ○ Therapeutic Use: Severe pneumonia to improve oxygenation. ○ Side Effects: Oxygen toxicity with prolonged use at high concentrations. Interesting Facts: COPD is a leading cause of death worldwide, and more than 90% of cases are related to smoking. Asthma affects 8-10% of the population, with children being especially vulnerable. Environmental triggers like dust mites and pollen can exacerbate symptoms. Pneumonia is responsible for 1 in 10 deaths worldwide, with elderly individuals being most at risk.